共 43 条
- [21] Re: Clinical Performance of Serum Isoform -2proPSA (p2PSA) and its Derivatives, Namely %p2PSA and PHI (Prostate Health Index) in Men Younger than 60 Years of Age: Results from a Multicentric European Study Editorial CommentJOURNAL OF UROLOGY, 2014, 192 (02): : 421 - 421Taneja, Samir S.
- [22] DIAGNOSTIC ACCURACY OF [-2]PROPSA (P2PSA) AND ITS DERIVATIVES %P2PSA AND PHI (PROSTATE HEALTH INDEX) IN A REAL CLINICAL SETTING OF CONTEMPORARY MEN UNDERGOING PROSTATE BIOPSY FOR SUSPECTED PROSTATE CANCEREUROPEAN UROLOGY SUPPLEMENTS, 2011, 10 (02) : 206 - 206Nava, L.Lazzeri, M.Lughezzani, G.Losa, A.Maga, T.Fabbri, F.Cestari, A.Maccagnano, C.Scattoni, VBini, VBuffi, N.Guazzoni, G.
- [23] Prospective evaluation of the utility of %p2PSA and the Prostate Health Index (PHI), in predicting prostate cancer in initial prostate biopsies of Singaporean men, with total PSA between 4.0 and 10 ng/mLBJU INTERNATIONAL, 2015, 116 : 3 - 3Gauhaar, VineetTan, Guan Lim LincolnGoh, Yen Seow Benjamin
- [24] THE ISOFORM [-2]PROPSA AND THE PROSTATE HEALTH INDEX (PHI) IMPROVE THE DETECTION OF PROSTATE CANCER FOR PATIENTS WITH TOTAL PSA BETWEEN 1.8 AND 8.0 NG/MLTUMOR BIOLOGY, 2010, 31 : S120 - S120Blanchet, J-SHoulgatte, A.Durand, X.Ramirez, J. N.Bensalah, K.Guille, B.Vincendeau, S.
- [25] Prospective evaluation of the utility of %P2psa and the Prostate Health Index (PHI), in predicting prostate cancer in initial prostate biopsies of Singaporean men, with total PSA between 4.0 and 10 ng/mlBJU INTERNATIONAL, 2015, 115 : 3 - 3Goh, Y. S. B.Tan, G. L. L.Tan, Y. K.Tai, B. C.Tan, K. M. L.Hawkins, R. C. W.Hong, F.Chiong, E.
- [26] P2PSA AND DERIVATIVES (% P2PSA AND PHI) ACCURATELY PREDICT PROSTATE CANCER IN OBESE MEN FROM A MULTICENTER PROSPECTIVE EUROPEAN STUDYJOURNAL OF UROLOGY, 2014, 191 (04): : E859 - E859Abrate, AlbertoLazzeri, MassimoBuffi, NicolomariaHaese, Alexanderde la Taille, AlexandreMcNicholas, ThomasPalou Redorta, JoanLughezzani, GiovanniGadda, Giulio MariaLista, GiulianaFossati, NicolaLarcher, AlessandroKinzikeeva, EllaDell'Oglio, PaoloMistretta, FrancescoBini, VittorioFreschi, MassimoGraefen, MarkusGuazzoni, Giorgio
- [27] Prostate health index significantly reduced unnecessary prostate biopsies in patients with PSA 2-10 ng/mL and PSA >10 ng/mL: Results from a Multicenter Study in ChinaPROSTATE, 2017, 77 (11): : 1221 - 1229Na, RongYe, DingweiQi, JunLiu, FangHelfand, Brian T.Brendler, Charles B.Conran, Carly A.Packiam, VigneshGong, JianWu, YishuoZheng, Siqun L.Mo, ZengnanDing, QiangSun, YinghaoXu, Jianfeng
- [28] Evaluation of Prostate-Specific Antigen Isoform p2PSA and Its Derivates, %p2PSA, Prostate Health Index and Prostate Dimension-Adjusted Related Index in the Detection of Prostate Cancer at First Biopsy: An Exploratory, Prospective StudyUROLOGIA INTERNATIONALIS, 2014, 93 (02) : 135 - 145Mearini, LuigiFerri, CarlaLazzeri, MassimoBini, VittorioNunzi, ElisabettaFiorini, DorianaCostantini, ElisabettaManasse, Gianluca CarloPorena, Massimo
- [29] [-2]PROPSA (P2PSA) AND ITS DERIVATIVES %P2PSA AND PHI (PROSTATE HEALTH INDEX) IN A REAL CLINICAL SETTING OF CONTEMPORARY MEN UNDERGOING PROSTATE BIOPSY FOR SUSPECTED PROSTATE CANCER. A SINGLE HIGH-VOLUME CENTER EXPERIENCEJOURNAL OF UROLOGY, 2011, 185 (04): : E919 - E920Nava, LucianoLazzeri, MassimoScattoni, VincenzoMaccagnano, CarmenLughezzani, GiovanniBuffi, NicoloFabbri, FabioLarcher, AiessandroBini, VittorioCestari, AndreaMontorsi, FrancescoRigatti, PatrizioGuazzoni, Giorgio
- [30] Clinical utility of the exosome based ExoDx Prostate(IntelliScore) EPI test in men presenting for initial Biopsy with a PSA 2-10 ng/mLPROSTATE CANCER AND PROSTATIC DISEASES, 2020, 23 (04) : 607 - 614Tutrone, RonaldDonovan, Michael J.Torkler, PhillippTadigotla, VasishtMcLain, TomNoerholm, MikkelSkog, JohanMcKiernan, James